search
Back to results

Evaluation of a Diabetes Self-Management Education Program for Non-Intensified Insulin Therapy in Type 2 Diabetes (MEDIAS-2-CT)

Primary Purpose

Type 2 Diabetes

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
MEDIAS 2 CT
Current CT program
Sponsored by
Forschungsinstitut der Diabetes Akademie Mergentheim
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Type 2 Diabetes focused on measuring diabetes self-management education, insulin therapy

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • type 2 diabetes
  • two years diabetes duration with oral treatment
  • BMI > 20 and < 40 kg/m²
  • written informed consent

Exclusion Criteria:

  • current psychiatric disease
  • dementia or other severe cognitive impairment
  • severe complications
  • severe conditions (e.g., cancer)
  • gestational diabetes.

Sites / Locations

  • Diabetes Centre Mergentheim

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

MEDIAS 2 CT

Current CT program

Arm Description

The MEDIAS CT is a newly developed education program for the initiation of a conventional insulin therapy in type 2 diabetic patients.

This program is currently used for the initiation of conventional insulin therapy in type 2 diabetic patients.

Outcomes

Primary Outcome Measures

A1c values

Secondary Outcome Measures

Quality of life
QoL will be assessed using the Short Form Health Survey (SF-12) questionnaire.
Diabetes knowledge
A diabetes knowledge test for insulin treatment in type 2 diabetes will be used
Diabetes related emotional burden
Diabetes related emotional burden / diabetes related distress will be assessed using the Problem Areas in Diabetes (PAID) questionnaire
Diabetes related distress
Second questionnaire for assessing diabetes related distress is the Diabetes Distress Scale (DDS)
Self-care behavior
The Summary of Diabetes Self-Care Activities (SDSCA) scale will be used.
Depression
The German version of the Center of Epidemiological Studies Depression Scale (CES-D) will be used.

Full Information

First Posted
April 13, 2016
Last Updated
August 8, 2016
Sponsor
Forschungsinstitut der Diabetes Akademie Mergentheim
search

1. Study Identification

Unique Protocol Identification Number
NCT02748239
Brief Title
Evaluation of a Diabetes Self-Management Education Program for Non-Intensified Insulin Therapy in Type 2 Diabetes
Acronym
MEDIAS-2-CT
Official Title
Evaluation of a Self-management Oriented Diabetes Education Program for the Initiation of Non-Intensive Insulin Therapy in Type 2 Diabetic Patients
Study Type
Interventional

2. Study Status

Record Verification Date
August 2016
Overall Recruitment Status
Completed
Study Start Date
February 2013 (undefined)
Primary Completion Date
February 2016 (Actual)
Study Completion Date
May 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Forschungsinstitut der Diabetes Akademie Mergentheim

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
A new diabetes education program for the initiation of non-intensive insulin therapy in type 2 diabetic patients (MEDIAS 2 CT) was developed. In the evaluation, this new developed program is compared with an education programs which is currently used for diabetes education. It is expected that the new developed program (MEDIAS 2 CT) can demonstrate non-inferiority with regard to the main outcome variable glycemic control. If non-inferiority can be demonstrated superiority of this program will be tested.
Detailed Description
The MEDIAS 2 CT program is based on a self-management/empowerment approach. It is conducted as a group program comprising 6 lessons of 90 minutes each. MEDIAS 2 CT was designed to help patients perform conventional insulin therapy. In addition, MEDIAS 2 CT focused on controlling metabolic risk factors (elevated lipids and blood pressure), coping with the risk of late complications, and reducing the emotional burden of diabetes and its treatment. The active comparator condition (ACC-CT) consisted of an established patient education program for type 2 diabetic patients with conventional insulin treatment. This education program was developed in the 1980s and 1990s and is more didactic-oriented, focusing primarily on the acquisition of knowledge, skills, and information about the correct treatment of diabetes. Both treatment arms (MEDIAS 2 CT and ACC) consisted of 6 lessons, which were conducted as group sessions.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes
Keywords
diabetes self-management education, insulin therapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
182 (Actual)

8. Arms, Groups, and Interventions

Arm Title
MEDIAS 2 CT
Arm Type
Active Comparator
Arm Description
The MEDIAS CT is a newly developed education program for the initiation of a conventional insulin therapy in type 2 diabetic patients.
Arm Title
Current CT program
Arm Type
Placebo Comparator
Arm Description
This program is currently used for the initiation of conventional insulin therapy in type 2 diabetic patients.
Intervention Type
Behavioral
Intervention Name(s)
MEDIAS 2 CT
Intervention Description
The MEDIAS 2 CT is a education program for the initiation of a conventional insulin therapy in type 2 diabetic patients. The program consists of 6 lessons and is conducted in group settings (4-8 participants).
Intervention Type
Behavioral
Intervention Name(s)
Current CT program
Intervention Description
The Current CT program is currently used for the initiation of conventional insulin therapy in type 2 diabetic patients. The program consists of 6 lessons and is conducted in group settings (4-8 participants).
Primary Outcome Measure Information:
Title
A1c values
Time Frame
six months follow up after termination of the programs
Secondary Outcome Measure Information:
Title
Quality of life
Description
QoL will be assessed using the Short Form Health Survey (SF-12) questionnaire.
Time Frame
six months follow up
Title
Diabetes knowledge
Description
A diabetes knowledge test for insulin treatment in type 2 diabetes will be used
Time Frame
six months follow up
Title
Diabetes related emotional burden
Description
Diabetes related emotional burden / diabetes related distress will be assessed using the Problem Areas in Diabetes (PAID) questionnaire
Time Frame
six months follow up
Title
Diabetes related distress
Description
Second questionnaire for assessing diabetes related distress is the Diabetes Distress Scale (DDS)
Time Frame
six months follow up
Title
Self-care behavior
Description
The Summary of Diabetes Self-Care Activities (SDSCA) scale will be used.
Time Frame
six months follow up
Title
Depression
Description
The German version of the Center of Epidemiological Studies Depression Scale (CES-D) will be used.
Time Frame
six months follow up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: type 2 diabetes two years diabetes duration with oral treatment BMI > 20 and < 40 kg/m² written informed consent Exclusion Criteria: current psychiatric disease dementia or other severe cognitive impairment severe complications severe conditions (e.g., cancer) gestational diabetes.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Norbert Hermanns, PHD
Organizational Affiliation
Forschungsinstitut der Diabetes Akademie Mergentheim
Official's Role
Principal Investigator
Facility Information:
Facility Name
Diabetes Centre Mergentheim
City
Bad Mergentheim
ZIP/Postal Code
97980
Country
Germany

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Evaluation of a Diabetes Self-Management Education Program for Non-Intensified Insulin Therapy in Type 2 Diabetes

We'll reach out to this number within 24 hrs